Advances in Molecular Imaging Strategies for in Vivo Tracking of Immune Cells

BioMed Research International

Volumn 2016, Issue , 2016, Pages

  Lee, Ho Won ^a   Gangadaran, Prakash ^a   Kalimuthu, Senthilkumar ^a   Ahn, Byeong Cheol ^a  

^a Kyungpook National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DENDRITIC CELL VACCINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

B LYMPHOCYTE; CANCER IMMUNIZATION; CELL LABELING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL TRACKING; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MEDICAL TECHNOLOGY; MOLECULAR IMAGING; NATURAL KILLER CELL; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROCESS OPTIMIZATION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; T LYMPHOCYTE; IMMUNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PROCEDURES; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY-COMPUTED TOMOGRAPHY; ULTRASTRUCTURE;

B-LYMPHOCYTES; CELL TRACKING; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY COMPUTED TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY COMPUTED TOMOGRAPHY; T-LYMPHOCYTES;

EID: 84990890522     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2016/1946585     Document Type: Review

References (100)

1. H.-J. Jeong, B. C. Lee, B.-C. Ahn, and K. W. Kang, "Development of drugs and technology for radiation theragnosis, " Nuclear Engineering and Technology, vol. 48, no. 3, pp. 597-607, 2016.
2. R. Weissleder and U. Mahmood, "Molecular imaging, " Radiology, vol. 219, no. 2, pp. 316-333, 2001.
3. H. Youn and K.-J. Hong, "In vivo non invasive molecular imaging for immune cell tracking in small animals, " Immune Network, vol. 12, no. 6, pp. 223-229, 2012.
4. Y.-W. Noh, Y. T. Lim, and B. H. Chung, "Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals, " FASEB Journal, vol. 22, no. 11, pp. 3908-3918, 2008.
5. P.-G. Ren, S.-W. Lee, S. Biswal, and S. B. Goodman, "Systemic trafficking ofmacrophages induced by bone cement particles in nude mice, " Biomaterials, vol. 29, no. 36, pp. 4760-4765, 2008.
6. F. Galli, A. S. Rapisarda, H. Stabile et al., "In vivo imaging of natural killer cell trafficking in tumors, " Journal of Nuclear Medicine, vol. 56, no. 10, pp. 1575-1580, 2015.
7. H. Wang, F. Cao, A. De et al., "Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging, " Stem Cells, vol. 27, no. 7, pp. 1548-1558, 2009.
8. J. W. M. Bulte, T. Douglas, B. Witwer et al., "Magnetodendrimers allowendosomalmagnetic labeling and in vivo tracking of stem cells, " Nature Biotechnology, vol. 19, no. 12, pp. 1141-1147, 2001.
9. J. E. Kim, S. Kalimuthu, and B.-C. Ahn, "In Vivo cell tracking with bioluminescence imaging, " Nuclear Medicine and Molecular Imaging, vol. 49, no. 1, pp. 3-10, 2015.
10. S. N. Histed, M. L. Lindenberg, E. Mena, B. Turkbey, P. L. Choyke, and K. A. Kurdziel, "Review of functional/anatomical imaging in oncology, " Nuclear Medicine Communications, vol. 33, no. 4, pp. 349-361, 2012.
11. B.-C. Ahn, "Requisites for successful theranostics with radionuclide-based reporter gene imaging, " Journal of Drug Targeting, vol. 22, no. 4, pp. 295-303, 2014.
12. R. Meir, K. Shamalov, O. Betzer et al., "Nanomedicine for cancer immunotherapy: Tracking cancer-specific T-cells in vivo with gold nanoparticles and CT imaging, " ACS Nano, vol. 9, no. 6, pp. 6363-6372, 2015.
13. M. Shilo, T. Reuveni, M. Motiei, and R. Popovtzer, "Nanoparticles as computed tomography contrast agents: current status and future perspectives, " Nanomedicine, vol. 7, no. 2, pp. 257-269, 2012.
14. E. T. Ahrens and J. W. M. Bulte, "Tracking immune cells in vivo using magnetic resonance imaging, " Nature Reviews Immunology, vol. 13, no. 10, pp. 755-763, 2013.
15. J. W. M. Bulte, "In vivo MRI cell tracking: clinical studies, " American Journal of Roentgenology, vol. 193, no. 2, pp. 314-325, 2009.
16. F. M. Youniss, G. Sundaresan, L. J. Grahamet al., "Near-infrared imaging of adoptiveimmune cell therapy in breast cancermodel using cell membrane labeling, " PLoS ONE, vol. 9, no. 10, Article ID e109162, 2014.
17. Z. Yang, Y. Wang, Y. Li, Q. Liu, Q. Zeng, and X. Xu, "Options for tracking GFP-Labeled transplanted myoblasts using in vivo fluorescence imaging: implications for tracking stem cell fate, " BMC Biotechnology, vol. 14, article 55, 2014.
18. G. L. Costa, M. R. Sandora, N. Nakajima et al., "Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit, " The Journal of Immunology, vol. 167, no. 4, pp. 2379-2387, 2001.
19. B. A. Rabinovich, Y. Ye, T. Etto et al., "Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetentmouse models of cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14342-14346, 2008.
20. S. Kang, H. W. Lee, Y. H. Jeon et al., "Combined fluorescence andmagnetic resonance imaging of primary macrophage migration to sites of acute inflammation using near-infrared fluorescent magnetic nanoparticles, " Molecular Imaging and Biology, vol. 17, no. 5, pp. 643-651, 2015.
21. L. Ottobrini, C. Martelli, D. L. Trabattoni, M. Clerici, and G. Lucignani, "In vivo imaging of immune cell trafficking in cancer, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 5, pp. 949-968, 2011.
22. R. Tavaré, H. Escuin-Ordinas, S. Mok et al., "An effective immuno-PET imaging method to monitor CD8-dependent responses to immunotherapy, " Cancer Research, vol. 76, no. 1, pp. 73-82, 2016.
23. C. M. Griessinger, R. Kehlbach, D. Bukala et al., "In vivo tracking of th1 cells by PET reveals quantitative and temporal distribution and specific homing in lymphatic tissue, " Journal of Nuclear Medicine, vol. 55, no. 2, pp. 301-307, 2014.
24. G. Antoch, L. S. Freudenberg, T. Beyer, A. Bockisch, and J. F. Debatin, "To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT, " Journal of Nuclear Medicine, vol. 45, supplement 1, pp. 56S-65S, 2004.
25. D. Delbeke, R. E. Coleman, M. J. Guiberteau et al., "Procedure guideline for tumor imaging with 18F-FDG PET/CT 1. 0, " Journal of Nuclear Medicine, vol. 47, no. 5, pp. 885-895, 2006.
26. P. Ray, A. De, J.-J. Min, R. Y. Tsien, and S. S. Gambhir, "Imaging tri-fusion multimodality reporter gene expression in living subjects, " Cancer Research, vol. 64, no. 4, pp. 1323-1330, 2004.
27. A. A. Neves and K. M. Brindle, "Assessing responses to cancer therapy using molecular imaging, " Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1766, no. 2, pp. 242-261, 2006.
28. V. Ponomarev, M. Doubrovin, I. Serganova et al., "Anovel triplemodality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging, " European Journal of Nuclear Medicine and Molecular Imaging, vol. 31, no. 5, pp. 740-751, 2004.
29. L. Ottobrini, P. Ciana, A. Biserni, G. Lucignani, and A. Maggi, "Molecular imaging: a new way to study molecular processes in vivo, "Molecular and Cellular Endocrinology, vol. 246, no. 1-2, pp. 69-75, 2006.
30. J. K. Willmann, N. van Bruggen, L. M. Dinkelborg, and S. S. Gambhir, "Molecular imaging in drug development, " Nature Reviews Drug Discovery, vol. 7, no. 7, pp. 591-607, 2008.
31. G. Lucignani, L. Ottobrini, C. Martelli, M. Rescigno, and M. Clerici, "Molecular imaging of cell-mediated cancer immunotherapy, " Trends in Biotechnology, vol. 24, no. 9, pp. 410-418, 2006.
32. M. Rodriguez-Porcel, "In vivo imaging and monitoring of transplanted stem cells: clinical applications, " Current Cardiology Reports, vol. 12, no. 1, pp. 51-58, 2010.
33. J. H. Kang and J.-K. Chung, "Molecular-genetic imaging based on reporter gene expression, " Journal of Nuclear Medicine, vol. 49, supplement 2, pp. 164S-179S, 2008.
34. M. Schuster, A. Nechansky, and R. Kircheis, "Cancer immunotherapy, " Biotechnology Journal, vol. 1, no. 2, pp. 138-147, 2006.
35. T. Hinz, C. J. Buchholz, T. van der Stappen, K. Cichutek, and U. Kalinke, "Manufacturing and quality control of cellbased tumor vaccines: a scientific and a regulatory perspective, " Journal of Immunotherapy, vol. 29, no. 5, pp. 472-476, 2006.
36. M. D. Cahalan, I. Parker, S. H. Wei, and M. J. Miller, "Twophoton tissue imaging: seeing the immune system in a fresh light, " Nature Reviews Immunology, vol. 2, no. 11, pp. 872-880, 2002.
37. S. Mandl, C. Schimmelpfennig, M. Edinger, R. S. Negrin, and C. H. Contag, "Understanding immune cell trafficking patterns via in vivo bioluminescence imaging, " Journal of Cellular Biochemistry, vol. 39, pp. 239-248, 2002.
38. E. Vacchelli, I. Vitale, A. Eggermont et al., "Trial watch: dendritic cell-based interventions for cancer therapy, " OncoImmunology, vol. 2, no. 10, Article IDe25771, 2013.
39. R. M. Steinman, K. Inaba, S. Turley, P. Pierre, and I. Mellman, "Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies, "Human Immunology, vol. 60, no. 7, pp. 562-567, 1999.
40. M. Cella, F. Sallusto, and A. Lanzavecchia, "Origin, maturation and antigen presenting function of dendritic cells, " Current Opinion in Immunology, vol. 9, no. 1, pp. 10-16, 1997.
41. R. M. Steinman, "The dendritic cell system and its role in immunogenicity, " Annual Review of Immunology, vol. 9, no. 1, pp. 271-296, 1991.
42. N. Burdin and P. Moingeon, "Cancer vaccines based on dendritic cells loaded with tumor-associated antigens, " Cell Biology and Toxicology, vol. 17, no. 2, pp. 67-75, 2001.
43. I. J. M. de Vries, D. J. E. B. Krooshoop, N. M. Scharenborg et al., "Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state, " Cancer Research, vol. 63, no. 1, pp. 12-17, 2003.
44. E. B. Olasz, L. Lang, J. Seidel, M. V. Green, W. C. Eckelman, and S. I. Katz, "Fluorine-18 labeledmouse bonemarrow-derived dendritic cells can be detected in vivo by high resolution projection imaging, " Journal of Immunological Methods, vol. 260, no. 1-2, pp. 137-148, 2002.
45. H. S. Kim, J. Woo, J. H. Lee et al., "In vivo tracking of dendritic cell using MRI reporter gene, ferritin, " PLoS ONE, vol. 10, no. 5, article e0125291, 2015.
46. Y. Xu, C. Wu, W. Zhu et al., "Superparamagnetic MRI probes for in vivo tracking of dendritic cell migration with a clinical 3 T scanner, " Biomaterials, vol. 58, pp. 63-71, 2015.
47. H. W. Lee, S. Y. Yoon, T. D. Singh et al., "Tracking of dendritic cell migration into lymph nodes using molecular imaging with sodiumiodide symporter and enhanced firefly luciferase genes, " Scientific Reports, vol. 5, article 9865, 2015.
48. R. Ridolfi, A. Riccobon, R. Galassi et al., "Evaluation of in vivo labelled dendritic cell migration in cancer patients, " Journal of Translational Medicine, vol. 2, no. 1, article 27, 2004.
49. H. E. Daldrup-Link, D. Golovko, B. Ruffell et al., "MRI of tumor-associated macrophages with clinically applicable iron oxide nanoparticles, " Clinical Cancer Research, vol. 17, no. 17, pp. 5695-5704, 2011.
50. A. Gramoun, L. A. Crowe, L. Maurizi et al., "Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages, " Arthritis Research andTherapy, vol. 16, no. 3, article R131, 2014.
51. H. W. Lee, Y. H. Jeon, M.-H. Hwang et al., "Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in amurine inflammation model, "Molecular Imaging and Biology, vol. 15, no. 6, pp. 703-712, 2013.
52. Y. J. Choi, S.-G. Oh, T. D. Singh et al., "Visualization of the biological behavior of tumor-associated macrophages in living mice with colon cancer using multimodal optical reporter gene imaging, " Neoplasia, vol. 18, no. 3, pp. 133-141, 2016.
53. J. H. Seo, Y. H. Jeon, Y. J. Lee et al., "Trafficking macrophage migration using reporter gene imaging with human sodium iodide symporter in animal models of inflammation, " Journal of Nuclear Medicine, vol. 51, no. 10, pp. 1637-1643, 2010.
54. A. Blykers, S. Schoonooghe, C. Xavier et al., "PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments, " Journal of NuclearMedicine, vol. 56, no. 8, pp. 1265-1271, 2015.
55. M. Srinivas, P. A. Morel, L. A. Ernst, D. H. Laidlaw, and E. T. Ahrens, "Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model, " Magnetic Resonance in Medicine, vol. 58, no. 4, pp. 725-734, 2007.
56. J. H. Chewning, K. J. Dugger, T. R. Chaudhuri, K. R. Zinn, and C. T. Weaver, "Bioluminescence-based visualization of CD4 T cell dynamics using a T lineage-specific luciferase transgenic model, " BMC Immunology, vol. 10, article 44, 2009.
57. H. Kim, G. Peng, J. M. Hicks et al., "Engineering human tumorspecific cytotoxic T cells to function in a hypoxic environment, " MolecularTherapy, vol. 16, no. 3, pp. 599-606, 2008.
58. C. J. Shu, C. G. Radu, S. M. Shelly et al., "Quantitative PET reporter gene imaging of CD8+ T cells specific for a melanomaexpressed self-antigen, " International Immunology, vol. 21, no. 2, pp. 155-165, 2009.
59. D. L. J. Thorek, P. Y. Tsao, V. Arora, L. Zhou, R. A. Eisenberg, and A. Tsourkas, "In vivo, multimodal imaging of B cell distribution and response to antibody immunotherapy in mice, " PLoS ONE, vol. 5, no. 5, Article IDe10655, 2010.
60. M. Walther, P. Gebhardt, P. Grosse-Gehling et al., "Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT, " Applied Radiation and Isotopes, vol. 69, no. 6, pp. 852-857, 2011.
61. H. E. Daldrup-Link, S. Tavri, P. Jha et al., "Optical imaging of cellular immunotherapy against prostate cancer, " Molecular Imaging, vol. 8, no. 1, pp. 15-26, 2009.
62. R. J. Melder, A. L. Brownell, T. M. Shoup, G. L. Brownell, and R. K. Jain, "Imaging of activated natural killer cells in mice by positron emission tomography: preferential uptake in tumors, " Cancer Research, vol. 53, no. 24, pp. 5867-5871, 1993.
63. L. Zamai, C. Ponti, P. Mirandola et al., "NK cells and cancer, " The Journal of Immunology, vol. 178, no. 7, pp. 4011-4016, 2007.
64. B. Meller, C. Frohn, J.-M. Brand et al., "Monitoring of a new approach of immunotherapy with allogenic 111In-labelled NK cells in patients with renal cell carcinoma, " European Journal of NuclearMedicine andMolecular Imaging, vol. 31, no. 3, pp. 403-407, 2004.
65. B. Burke, S. Sumner, N. Maitland, and C. E. Lewis, "Macrophages in gene therapy: cellular delivery vehicles and in vivo targets, " Journal of Leukocyte Biology, vol. 72, no. 3, pp. 417-428, 2002.
66. D. Orlic, J. Kajstura, S. Chimenti et al., "Bone marrow cells regenerate infarcted myocardium, " Nature, vol. 410, no. 6829, pp. 701-705, 2001.
67. M. Feldmann and L. Steinman, "Design of effective immunotherapy for human autoimmunity, " Nature, vol. 435, no. 7042, pp. 612-619, 2005.
68. A. Chawla, "Control of macrophage activation and function by PPARs, " Circulation Research, vol. 106, no. 10, pp. 1559-1569, 2010.
69. S. Gordon and P. R. Taylor, "Monocyte and macrophage heterogeneity, " Nature Reviews Immunology, vol. 5, no. 12, pp. 953-964, 2005.
70. J. S. Lee, H. J. Kang, G. Gong et al., "MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice, " Radiology, vol. 241, no. 1, pp. 142-148, 2006.
71. J. Sloan-Lancaster, B. D. Evavold, and P. M. Allen, "Induction of T-cell anergy by altered T-cell-receptor ligand on live antigenpresenting cells, " Nature, vol. 363, no. 6425, pp. 156-159, 1993.
72. K.-H. Lee, A. D. Holdorf, M. L. Dustin, A. C. Chan, P. M. Allen, and A. S. Shaw, "T cell receptor signaling precedes immunological synapse formation, " Science, vol. 295, no. 5559, pp. 1539-1542, 2002.
73. A. Viola and A. Lanzavecchia, "T cell activation determined by T cell receptor number and tunable thresholds, " Science, vol. 273, no. 5271, pp. 104-106, 1996.
74. T. R. Mosmann, H. Cherwinski, and M. W. Bond, "Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins, " Journal of Immunology, vol. 136, no. 7, pp. 2348-2357, 1986.
75. S. L. Swain, L. M. Bradley, M. Croft et al., "Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development, " Immunological Reviews, vol. 123, no. 1, pp. 115-144, 1991.
76. M. L. Albert, B. Sauter, and N. Bhardwaj, "Dendritic cells acquire antigen from apoptotic cells and induce class Irestricted CTLS, " Nature, vol. 392, no. 6671, pp. 86-89, 1998.
77. J. A. Trapani and M. J. Smyth, "Functional significance of the perforin/granzyme cell death pathway, " Nature Reviews Immunology, vol. 2, no. 10, pp. 735-747, 2002.
78. L. Liu, Q. Ye, Y. Wu et al., "Tracking T-cells in vivo with a new nano-sized MRI contrast agent, " Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 8, no. 8, pp. 1345-1354, 2012.
79. P. J. Maglione and J. Chan, "How B cells shape the immune response againstMycobacteriumtuberculosis, " European Journal of Immunology, vol. 39, no. 3, pp. 676-686, 2009.
80. J. R. Dunkelberger and W.-C. Song, "Complement and its role in innate and adaptive immune responses, " Cell Research, vol. 20, no. 1, pp. 34-50, 2010.
81. A. Rot and U. H. Von Andrian, "Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells, " Annual Review of Immunology, vol. 22, pp. 891-928, 2004.
82. K. L. Calame, "Plasma cells: finding new light at the end of B cell development, " Nature Immunology, vol. 2, no. 12, pp. 1103-1108, 2001.
83. B. Heyman, "Regulation of antibody responses via antibodies, complement, and Fc receptors, " Annual Review of Immunology, vol. 18, pp. 709-737, 2000.
84. H. W. Schroeder Jr. and L. Cavacini, "Structure and function of immunoglobulins, " Journal of Allergy and Clinical Immunology, vol. 125, no. 2, pp. S41-S52, 2010.
85. T. W. LeBien and T. F. Tedder, "B lymphocytes: howthey develop and function, " Blood, vol. 112, no. 5, pp. 1570-1580, 2008.
86. P. Engel, J. A. Gómez-Puerta, M. Ramos-Casals, F. Lozano, and X. Bosch, "Therapeutic targeting of B cells for rheumatic autoimmune diseases, " Pharmacological Reviews, vol. 63, no. 1, pp. 127-156, 2011.
87. C. C. Mok and C. S. Lau, "Pathogenesis of systemic lupus erythematosus, " Journal of Clinical Pathology, vol. 56, no. 7, pp. 481-490, 2003.
88. J. L. Browning, "B cells move to centre stage: novel opportunities for autoimmune disease treatment, " Nature Reviews Drug Discovery, vol. 5, no. 7, pp. 564-576, 2006.
89. E. Vivier, E. Tomasello, M. Baratin, T. Walzer, and S. Ugolini, "Functions of natural killer cells, " Nature Immunology, vol. 9, no. 5, pp. 503-510, 2008.
90. T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier, "Natural-killer cells and dendritic cells: 'l'union fait la force", " Blood, vol. 106, no. 7, pp. 2252-2258, 2005.
91. E. O. Long, H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan, "Controlling natural killer cell responses: integration of signals for activation and inhibition, " Annual Review of Immunology, vol. 31, no. 1, pp. 227-258, 2013.
92. H. J. Pegram, D. M. Andrews, M. J. Smyth, P. K. Darcy, and M. H. Kershaw, "Activating and inhibitory receptors of natural killer cells, " Immunology and Cell Biology, vol. 89, no. 2, pp. 216-224, 2011.
93. R. M. Welsh, "Natural killer cells and interferon, " Critical Reviews in Immunology, vol. 5, no. 1, pp. 55-93, 1984.
94. T. A. Fehniger, M. H. Shah, M. J. Turner et al., "Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response, " Journal of Immunology, vol. 162, no. 8, pp. 4511-4520, 1999.
95. B. R. Lauwerys, J.-C. Renauld, and F. A. Houssiau, "Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18, " Cytokine, vol. 11, no. 11, pp. 822-830, 1999.
96. J.-M. Brand, B. Meller, K. Von Hof et al., "Kinetics and organ distribution of allogeneic natural killer lymphocytes transfused intopatients sufferingfromrenal cell carcinoma, " StemCells and Development, vol. 13, no. 3, pp. 307-314, 2004.
97. L. Matera, A. Galetto, M. Bello et al., "In vivo migration of labeled autologous natural killer cells to liver metastases in patients with colon carcinoma, " Journal of Translational Medicine, vol. 4, article 49, 2006.
98. R. Meier, M. Piert, G. Piontek et al., "Tracking of [18F]FDGlabeled natural killer cells to HER2/neu-positive tumors, " Nuclear Medicine and Biology, vol. 35, no. 5, pp. 579-588, 2008.
99. M. Edinger, Y.-A. Cao, M. R. Verneris, M. H. Bachmann, C. H. Contag, and R. S. Negrin, "Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging, " Blood, vol. 101, no. 2, pp. 640-648, 2003.
100. H. E. Daldrup-Link, R. Meier, M. Rudelius et al., "In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging, " European Radiology, vol. 15, no. 1, pp. 4-13, 2005.